NL6815755A - - Google Patents
Info
- Publication number
- NL6815755A NL6815755A NL6815755A NL6815755A NL6815755A NL 6815755 A NL6815755 A NL 6815755A NL 6815755 A NL6815755 A NL 6815755A NL 6815755 A NL6815755 A NL 6815755A NL 6815755 A NL6815755 A NL 6815755A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT1064767A AT280290B (de) | 1967-11-24 | 1967-11-24 | Verfahren zur Herstellung von neuen 1-Phenyl-4-alkyl-3H-1,4-benzodiazepin-2,5-[1H,4H]-dionen |
Publications (1)
Publication Number | Publication Date |
---|---|
NL6815755A true NL6815755A (xx) | 1969-05-28 |
Family
ID=3623762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL6815755A NL6815755A (xx) | 1967-11-24 | 1968-11-05 |
Country Status (13)
Country | Link |
---|---|
AT (1) | AT280290B (xx) |
BE (1) | BE724364A (xx) |
BR (1) | BR6804236D0 (xx) |
CH (1) | CH523265A (xx) |
DE (1) | DE1810423B2 (xx) |
DK (1) | DK124950B (xx) |
ES (2) | ES360410A1 (xx) |
FR (2) | FR1593335A (xx) |
GB (1) | GB1173540A (xx) |
IE (1) | IE32504B1 (xx) |
IL (1) | IL31146A (xx) |
NL (1) | NL6815755A (xx) |
SE (1) | SE356979B (xx) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3914216A (en) * | 1962-12-18 | 1975-10-21 | Boehringer Sohn Ingelheim | 1-Phenyl-3H-1,4-benzodiazepine-2,5-(1H,4H)-diones |
DE2117438A1 (de) * | 1971-04-08 | 1972-10-19 | CH. Boehringer Sohn, 6507 Ingelheim | Neue substituiert 1,3-Dihydro-2H-1 ^-benzodiazepine^-one |
BE793460A (fr) * | 1971-12-29 | 1973-06-28 | Boehringer Sohn Ingelheim | Nouvelles 1-aryl-3h,1,4-benzodiazepine-2,5-(1h |
US20060025388A1 (en) | 1999-04-30 | 2006-02-02 | Glick Gary D | Compositions and methods relating to novel compounds and targets thereof |
US7572788B2 (en) | 1999-04-30 | 2009-08-11 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
US7276348B2 (en) | 1999-04-30 | 2007-10-02 | Regents Of The University Of Michigan | Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof |
IL146222A0 (en) * | 1999-04-30 | 2002-07-25 | Univ Michigan | Therapeutic applications of pro-apoptotic benzodiazepines |
US7691582B2 (en) | 2002-09-27 | 2010-04-06 | The Regents Of The University Of Michigan | Methods of secretory vimentin detection and modulation |
CA2593019A1 (en) | 2005-01-03 | 2006-07-13 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
WO2007053193A2 (en) | 2005-06-01 | 2007-05-10 | The Regents Of The University Of Michigan | Unsolvated benzodiazepine compositions and methods |
CA2779041A1 (en) | 2005-11-01 | 2007-05-10 | The Regents Of The University Of Michigan | Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties |
US7759338B2 (en) | 2006-04-27 | 2010-07-20 | The Regents Of The University Of Michigan | Soluble 1,4 benzodiazepine compounds and stable salts thereof |
EP2037741B1 (en) | 2006-06-09 | 2013-11-27 | The Regents Of The University Of Michigan | Benzodiazepine derivatives for use in the treatment of immune, inflammatory and proliferative disorders |
EP2139331B1 (en) | 2007-03-09 | 2013-02-20 | The Regents of the University of Michigan | Compositions and methods relating to novel compounds and targets thereof |
AU2008251557B2 (en) * | 2007-05-10 | 2012-12-06 | Albany Molecular Research, Inc. | Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
CN101855203B (zh) | 2007-09-14 | 2014-03-19 | 密执安州立大学董事会 | F1f0-atp合成酶抑制剂以及相关的方法 |
UA99839C2 (ru) | 2007-11-06 | 2012-10-10 | Дзе Риджентс Оф Дзе Юниверсити Оф Мичиган | Бензодиазепиноновые соединения, применяемые при лечении кожных состояний |
WO2010030891A2 (en) | 2008-09-11 | 2010-03-18 | The Regents Of The University Of Michigan | Aryl guanidine f1f0-atpase inhibitors and related methods |
WO2010121164A2 (en) | 2009-04-17 | 2010-10-21 | The Regents Of The University Of Michigan | 1,4-benzodiazepinone compounds and their use in treating cancer |
JP2013505258A (ja) | 2009-09-18 | 2013-02-14 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | ベンゾジアゼピノン化合物およびそれを使用する治療方法 |
EP2501387B1 (en) | 2009-11-17 | 2016-07-27 | The Regents Of The University Of Michigan | 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
ES2703752T3 (es) | 2009-11-17 | 2019-03-12 | Univ Michigan Regents | 1,4-Benzodiazepina-2,5-dionas y compuestos relacionados que presentan propiedades terapéuticas |
EP3043790B1 (en) * | 2013-09-11 | 2021-05-26 | The Administrators of the Tulane Educational Fund | Novel anthranilic amides and the use thereof |
-
1967
- 1967-11-24 AT AT1064767A patent/AT280290B/de not_active IP Right Cessation
-
1968
- 1968-11-05 NL NL6815755A patent/NL6815755A/xx unknown
- 1968-11-06 SE SE15032/68A patent/SE356979B/xx unknown
- 1968-11-19 ES ES360410A patent/ES360410A1/es not_active Expired
- 1968-11-20 DK DK566968AA patent/DK124950B/da unknown
- 1968-11-22 BE BE724364A patent/BE724364A/fr unknown
- 1968-11-22 DE DE19681810423 patent/DE1810423B2/de active Granted
- 1968-11-22 FR FR1593335D patent/FR1593335A/fr not_active Expired
- 1968-11-22 CH CH1742668A patent/CH523265A/de not_active IP Right Cessation
- 1968-11-22 BR BR204236/68A patent/BR6804236D0/pt unknown
- 1968-11-22 IE IE1425/68A patent/IE32504B1/xx unknown
- 1968-11-24 IL IL31146A patent/IL31146A/en unknown
- 1968-11-25 GB GB55844/68A patent/GB1173540A/en not_active Expired
-
1969
- 1969-02-21 FR FR183259A patent/FR8310M/fr not_active Expired
-
1970
- 1970-04-23 ES ES378977A patent/ES378977A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
ES378977A1 (es) | 1973-01-16 |
BR6804236D0 (pt) | 1973-02-08 |
IL31146A0 (en) | 1969-01-29 |
DE1810423B2 (de) | 1973-03-22 |
AT280290B (de) | 1970-04-10 |
BE724364A (xx) | 1969-05-22 |
DE1810423C3 (xx) | 1973-10-11 |
GB1173540A (en) | 1969-12-10 |
IL31146A (en) | 1972-04-27 |
FR1593335A (xx) | 1970-05-25 |
CH523265A (de) | 1972-05-31 |
FR8310M (xx) | 1970-11-23 |
SE356979B (xx) | 1973-06-12 |
DK124950B (da) | 1972-12-11 |
IE32504B1 (en) | 1973-08-22 |
DE1810423A1 (de) | 1969-10-09 |
IE32504L (en) | 1969-05-24 |
ES360410A1 (es) | 1970-11-01 |